Lisa Yelland

Research Interests

Biostatistics Clinical Trials Maternal Health Pediatrics Public Health Pregnancy and Birth

APrf Lisa Yelland

School of Public Health

College of Health

Eligible to supervise Masters and PhD - email supervisor to discuss availability.

Associate Professor Lisa Yelland is a Biostatistician Senior Research Fellow in the Women and Kids Theme and Co-Leader of the Biostatistics Unit at the South Australian Health and Medical Research Institute. She is also an Affiliate Associate Professor in the School of Public Health at The University of Adelaide. As a biostatistician and clinical trialist specializing in maternal and infant health, her research broadly aims to drive improvements in the health of mothers, babies and other populations by using innovative statistical approaches to improve trial design and analysis. She is currently investigating methods for designing and analysing clinical trials collecting partially clustered data, and methods for addressing imperfect stratification in the analysis of trials that utilise stratified randomisation.

Date Institution name Country Title
The University of Adelaide Australia Doctor of Philosophy
The University of Adelaide Australia Bachelor of Mathematical and Computer Sciences (Honours)
The University of Adelaide Australia Bachelor of Science in the School of Mathematical and Computer Science

Year Citation
2025 Psaltis, P. J., Nguyen, M. T., Singh, K., Sinhal, A., Wong, D. T. L., Alcock, R., . . . Nicholls, S. J. (2025). Optical coherence tomography assessment of the impact of colchicine on non-culprit coronary plaque composition after myocardial infarction. Cardiovascular Research, 121(3), 468-478.
DOI Scopus19 WoS22 Europe PMC20
2025 Robledo, K. P., Libesman, S., & Yelland, L. N. (2025). We should do better in accounting for multiple births in neonatal randomised trials: a methodological systematic review. Archives of Disease in Childhood: Fetal and Neonatal Edition, 110(4), F362-F368.
DOI Scopus1 WoS2 Europe PMC1
2025 Shepherd, E., McIntyre, S., Rumbold, A., Karim, T., Goldsmith, S., Keir, A., . . . Yelland, L. (2025). Increasing Use of Antenatal Magnesium Sulphate Prior to Preterm Birth for Preventing Cerebral Palsy in Australia and New Zealand, 2012–2020: A Binational Registry Study. Australian and New Zealand Journal of Obstetrics and Gynaecology, 65(4), 13937-1-13937-5.
DOI
2025 Robledo, K. P., Libesman, S., & Yelland, L. N. (2025). Accounting for twins in statistical analyses could change conclusions. European Journal of Pediatrics, 184(5), 292-1-292-2.
DOI
2025 Lange, K. M., Kasza, J., Sullivan, T. R., & Yelland, L. N. (2025). Sample Size Calculations for Partially Clustered Trials. Statistics in Medicine, 44(15-17), e70172-1-e70172-17.
DOI
2025 Best, K. P., Yelland, L. N., Ge, L., Shi, Z., Leemaqz, S., Gibson, R., . . . Middleton, P. (2025). Maternal phthalate exposure, gestational length, and preterm birth risk: a prospective cohort study nested within a randomised trial. BMC Pregnancy and Childbirth, 25(1), 830-1-830-11.
DOI
2025 Rumbold, A. R., Lai, M. M., August, D., Koorts, P., Donovan, T., Yelland, L., . . . Keir, A. (2025). Supplemental Donor Milk vs Infant Formula in Moderate to Late Preterm InfantsA Randomized Clinical Trial. JAMA Pediatrics, 179(10), 1065-1073.
DOI
2025 Best, K. P., Northcott, C., Simmonds, L. A., Middleton, P., Yelland, L. N., Moffa, V., . . . Makrides, M. (2025). The early implementation phase of the Omega-3 Test-and-Treat Program for reducing the risk of preterm birth, South Australia, 2021-22: an implementation evaluation study. Medical Journal of Australia, 223(11), 626-633.
DOI
2025 Mugford, M., Arman, B. M., Kumar, K., Kaluve, R. S., Tran, D. X. A., Best, K., . . . Gibson, R. A. (2025). Associations between fatty acids providing support for n-3 and n-6 pathways are strongest in pregnant Indian vegetarians compared with pregnant Australian omnivores. Prostaglandins Leukotrienes and Essential Fatty Acids, 207, 102714.
DOI
2024 Lange, K. M., Sullivan, T. R., Kasza, J., & Yelland, L. N. (2024). Performance of mixed effects models and generalized estimating equations for continuous outcomes in partially clustered trials including both independent and paired data. Statistics in Medicine, 43(25), 4819-4835.
DOI Scopus2 WoS3 Europe PMC2
2024 Sullivan, T. R., Morris, T. P., Kahan, B. C., Cuthbert, A. R., & Yelland, L. N. (2024). Categorisation of continuous covariates for stratified randomisation: How should we adjust?. Statistics in Medicine, 43(11), 2083-2095.
DOI Scopus8 WoS8 Europe PMC6
2024 Gould, J. F., Cuthbert, A. R., Yelland, L. N., Gibson, R. A., Smithers, L. G., Zhou, S. J., & Makrides, M. (2024). Association of cord blood vitamin D with child neurodevelopment at 7 years of age. Journal of Paediatrics and Child Health, 60(7), 312-322.
DOI Scopus2 WoS2 Europe PMC2
2024 Gould, J. F., Gibson, R. A., Yelland, L. N., Colombo, J., McPhee, A. J., Gallier, S., . . . Makrides, M. (2024). Infant formula supplemented with milk fat globule membrane compared with standard infant formula for the cognitive development of healthy term-born formula-fed infants: protocol for a randomised controlled trial. BMJ Open, 14(6), e083399-1-e083399-13.
DOI Scopus2 WoS2
2023 Yelland, L. N., Sullivan, T. R., Gibson, R. A., Simmonds, L. A., Thakkar, S. K., Huang, F., . . . Makrides, M. (2023). Identifying women who may benefit from higher dose omega-3 supplementation during pregnancy to reduce their risk of prematurity: exploratory analyses from the ORIP trial.. BMJ Open, 13(4), e070220.
DOI Scopus4 WoS4 Europe PMC5
2023 Best, K. P., Yelland, L. N., Collins, C. T., McPhee, A. J., Rogers, G. B., Choo, J., . . . Makrides, M. (2023). Growth of late preterm infants fed nutrient-enriched formula to 120 days corrected age-A randomized controlled trial.. Frontiers in pediatrics, 11, 1146089.
DOI WoS1 Europe PMC1
2023 Yelland, L. N., Louise, J., Kahan, B. C., Morris, T. P., Lee, K. J., & Sullivan, T. R. (2023). Handling misclassified stratification variables in the analysis of randomised trials with continuous outcomes. Statistics in Medicine, 42(19), 1-18.
DOI Scopus6 WoS5 Europe PMC3
2023 Sullivan, T. R., Yelland, L. N., Gibson, R. A., Thakkar, S. K., Huang, F., Best, K. P., . . . Makrides, M. (2023). Predictors of compliance with higher dose omega-3 fatty acid supplementation during pregnancy and implications for the risk of prematurity: exploratory analysis of the ORIP randomised trial. BMJ Open, 13(9), e076507-1-e076507-8.
DOI Scopus1 WoS1 Europe PMC1
2023 Lange, K. M., Kasza, J., Sullivan, T. R., & Yelland, L. N. (2023). Partially clustered designs for clinical trials: Unifying existing designs using consistent terminology. Clinical Trials, 20(2), 99-110.
DOI Scopus10 WoS10 Europe PMC9
2022 Yelland, L. N., Scurrah, K. J., Ferreira, P., Calais-Ferreira, L., Rankin, M., Denton, J., . . . Craig, J. M. (2022). Conducting clinical trials in twin populations: a review of design, analysis, recruitment and ethical issues for twin-only trials. Twin Research and Human Genetics, 24(6), 359-364.
DOI Scopus3 WoS4 Europe PMC6
2022 Gibson, R. A., Makrides, M., Sullivan, T., Yelland, L. N., & Best, K. P. (2022). Response to Jackson and Harris, 2022;179:102417. Prostaglandins, Leukotrienes and Essential Fatty Acids, 182, 102454-1-102454-2.
DOI Scopus1 Europe PMC1
2022 Gould, J. F., Yelland, L. N., Gibson, R. A., McPhee, A. J., Varghese, J., Grivell, R., & Makrides, M. (2022). Protocol for a multicentre prospective observational study of families with full-term infants on postnatal wards and in the community to capture feeding practices across the first year of life: the Mother Infant Lactation Questionnaire (MILQ) study. BMJ Open, 12(10), e066355-1-e066355-6.
DOI Scopus3 WoS4 Europe PMC4
2021 Chan, K., Gallant, J., Leemaqz, S., Baldwin, D. A., Borath, M., Kroeun, H., . . . Whitfield, K. C. (2021). Assessment of salt intake to consider salt as a fortification vehicle for thiamine in Cambodia. Annals of the New York Academy of Sciences, 1498(1), 85-95.
DOI Scopus12 WoS12 Europe PMC10
2021 Wassie, M. M., Smithers, L. G., Yelland, L. N., Makrides, M., & Zhou, S. J. (2021). Associations between newborn thyroid stimulating hormone concentration and neurodevelopment and growth of children at 18 months. The British Journal of Nutrition, 126(10), 1478-1488.
DOI Scopus4 WoS4 Europe PMC3
2021 Gallant, J., Chan, K., Green, T. J., Wieringa, F. T., Leemaqz, S., Ngik, R., . . . Whitfield, K. C. (2021). Low-dose thiamine supplementation of lactating Cambodian mothers improves human milk thiamine concentrations: a randomized controlled trial. American Journal of Clinical Nutrition, 114(1), 90-100.
DOI Scopus19 WoS17 Europe PMC17
2021 Sullivan, T. R., Yelland, L. N., Moreno-Betancur, M., & Lee, K. J. (2021). Multiple imputation for handling missing outcome data in randomized trials involving a mixture of independent and paired data. Statistics in Medicine, 40(27), 6008-6020.
DOI Scopus6 WoS6 Europe PMC6
2021 Gould, J. F., Anderson, P. J., Yelland, L. N., Gibson, R. A., & Makrides, M. (2021). The influence of Prenatal DHA supplementation on individual domains of behavioral functioning in school‐aged children: Follow‐up of a randomized controlled trial. Nutrients, 13(9), 2996-1-2996-20.
DOI Scopus4 WoS4 Europe PMC3
2021 Simmonds, L. A., Yelland, L. N., Best, K. P., Liu, G., Gibson, R. A., & Makrides, M. (2021). Translating n-3 polyunsaturated fatty acid status from whole blood to plasma and red blood cells during pregnancy: Translating n-3 status across blood fractions in pregnancy.. Prostaglandins, Leukotrienes and Essential Fatty Acids, 176, 102367.
DOI Scopus10 WoS8 Europe PMC6
2020 Ramsden, C. E., Makrides, M., Yuan, Z. -X., Horowitz, M. S., Zamora, D., Yelland, L. N., . . . Gibson, R. A. (2020). Plasma oxylipins and unesterified precursor fatty acids are altered by DHA supplementation in pregnancy: can they help predict risk of preterm birth?. Prostaglandins, Leukotrienes and Essential Fatty Acids, 153, 102041-1-102041-9.
DOI Scopus21 WoS21 Europe PMC18
2020 Simmonds, L. A., Sullivan, T. R., Skubisz, M., Middleton, P. F., Best, K. P., Yelland, L. N., . . . Makrides, M. (2020). Omega-3 fatty acid supplementation in pregnancy - baseline omega-3 status and early preterm birth: exploratory analysis of a randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology, 127(8), 975-981.
DOI Scopus75 WoS63 Europe PMC54
2020 Samson, K. L. I., Loh, S. P., Khor, G. L., Mohd Shariff, Z., Yelland, L. N., Leemaqz, S., . . . Karakochuk, C. D. (2020). Effect of once weekly folic acid supplementation on erythrocyte folate concentrations in women to determine potential to prevent neural tube defects: a randomised controlled dose-finding trial in Malaysia.. BMJ open, 10(2), e034598.
DOI Scopus8 WoS7 Europe PMC4
2020 Makrides, M., Best, K., Yelland, L., McPhee, A., Zhou, S., Quinlivan, J., . . . Gibson, R. (2020). A Randomized Trial of Prenatal n-3 Fatty Acid Supplementation and Preterm Delivery. Obstetrical and Gynecological Survey, 75(2), 79-80.
DOI
2020 Hewawasam, E., Collins, C. T., Muhlhausler, B. S., Yelland, L. N., Smithers, L. G., Colombo, J. C., . . . Gould, J. F. (2020). Docosahexaenoic acid supplementation in infants born preterm and the effect on attention at 18 months' corrected age: follow-up of a subset of the N3RO randomised controlled trial. The British Journal of Nutrition, 125(4), 1-26.
DOI Scopus21 WoS21 Europe PMC16
2020 Best, K. P., Gibson, R. A., Yelland, L. N., Leemaqz, S., Gomersall, J., Liu, G., & Makrides, M. (2020). Effect of omega-3 lcpufa supplementation on maternal fatty acid and oxylipin concentrations during pregnancy. Prostaglandins Leukot Essent Fatty Acids, 162, 102181-1-102181-9.
DOI Scopus7 WoS7 Europe PMC6
2020 Gawlik, N. R., Makrides, M., Kettler, L., Yelland, L. N., Leemaqz, S., & Gould, J. F. (2020). The influence of DHA supplementation during pregnancy on language development across childhood: follow-up of a randomised controlled trial. Prostaglandins, Leukotrienes and Essential Fatty Acids, 163, 102207-1-102207-12.
DOI Scopus3 WoS3 Europe PMC2
2020 Samson, K. L. I., Loh, S. P., Lee, S. S., Sulistyoningrum, D. C., Khor, G. L., Shariff, Z. B. M., . . . Green, T. J. (2020). Weekly iron-folic acid supplements containing 2.8 mg folic acid are associated with a lower risk of neural tube defects than the current practice of 0.4 mg: a randomised controlled trial in Malaysia.. BMJ Glob Health, 5(12), 1-9.
DOI Scopus14 WoS10 Europe PMC6
2019 Whitfield, K. C., Kroeun, H., Green, T., Wieringa, F. T., Borath, M., Sophonneary, P., . . . Gallant, J. (2019). Thiamine dose response in human milk with supplementation among lactating women in Cambodia: study protocol for a double-blind, four-parallel arm randomised controlled trial. BMJ Open, 9(7), e029255-1-e029255-9.
DOI Scopus10 WoS9 Europe PMC6
2019 Wassie, M. M., Yelland, L. N., Smithers, L. G., Ranieri, E., & Zhou, S. J. (2019). Comparison of iodine status pre- and post-mandatory iodine fortification of bread in South Australia: a population study using newborn thyroid-stimulating hormone concentration as a marker. Public Health Nutrition, 22(16), 3063-3072.
DOI Scopus4 WoS4 Europe PMC4
2019 Makrides, M., Best, K., Yelland, L., McPhee, A., Zhou, S., Quinlivan, J., . . . Gibson, R. (2019). A randomized trial of prenatal n-3 fatty acid supplementation and preterm delivery. The New England journal of medicine, 381(11), 1035-1045.
DOI Scopus84 WoS69 Europe PMC55
2018 Sumathipala, A., Yelland, L., Green, D., Shepherd, T., Jayaweera, K., Ferreira, P., & Craig, J. (2018). Twins as participants in randomized controlled trials: a review of published literature. Twin Research and Human Genetics, 21(1), 51-56.
DOI Scopus11 WoS8 Europe PMC7
2018 Dodd, J., McPhee, A., Deussen, A., Louise, J., Yelland, L., Owens, J., & Robinson, J. (2018). Effects of an antenatal dietary intervention in overweight and obese women on 6 month infant outcomes: follow-up from the LIMIT randomised trial. International Journal of Obesity, 42(7), 1326-1335.
DOI Scopus26 WoS32 Europe PMC20
2018 Yelland, L., Kahan, B., Dent, E., Lee, K., Voysey, M., Forbes, A., & Cook, J. (2018). Prevalence and reporting of recruitment, randomisation and treatment errors in clinical trials: a systematic review. Clinical Trials, 15(3), 278-285.
DOI Scopus17 WoS14 Europe PMC14
2018 Yelland, L., Sullivan, T., Collins, C., Price, D., Mcphee, A., & Lee, K. (2018). Accounting for twin births in sample size calculations for randomised trials. Paediatric and Perinatal Epidemiology, 32(4), 380-387.
DOI Scopus13 WoS11 Europe PMC11
2018 Yelland, L. N., Schuit, E., Zamora, J., Middleton, P. F., Lim, A. C., Nassar, A. H., . . . Gates, S. (2018). Correlation between neonatal outcomes of twins depends on the outcome: secondary analysis of twelve randomised controlled trials. BJOG, 125(11), 1406-1413.
DOI Scopus9 WoS10 Europe PMC9
2017 Lei, Y., Carlson, S., Yelland, L., Makrides, M., Gibson, R., & Gajewski, B. (2017). Comparison of dichotomized and distributional approaches in rare event clinical trial design: a fixed Bayesian design. Journal of Applied Statistics, 44(8), 1466-1478.
DOI Scopus5 WoS5 Europe PMC4
2017 Gould, J. F., Anderson, A. J., Yelland, L. N., Smithers, L. G., Skeaff, C. M., Zhou, S. J., . . . Makrides, M. (2017). Association of cord blood vitamin D with early childhood growth and neurodevelopment. Journal of Paediatrics and Child Health, 53(1), 75-83.
DOI Scopus51 WoS42 Europe PMC41
2017 Yelland, L., Sullivan, T., Price, D., & Lee, K. (2017). Sample size calculations for randomised trials including both independent and paired data. Statistics in Medicine, 36(8), 1227-1239.
DOI Scopus20 WoS18 Europe PMC16
2017 Moran, L., Fraser, L., Sundernathan, T., Deussen, A., Louise, J., Yelland, L., . . . Dodd, J. (2017). The effect of an antenatal lifestyle intervention in overweight and obese women on circulating cardiometabolic and inflammatory biomarkers: secondary analyses from the LIMIT randomised trial. BMC Medicine, 15(1), 1-12.
DOI Scopus19 WoS18 Europe PMC18
2017 Gould, J., Treyvaud, K., Yelland, L., Anderson, P., Smithers, L., McPhee, A., & Makrides, M. (2017). Seven-year follow-up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA, 317(11), 1173-1175.
DOI Scopus50 WoS42 Europe PMC32
2017 Sullivan, T., Yelland, L., Lee, K., Ryan, P., & Salter, A. (2017). Treatment of missing data in follow-up studies of randomised controlled trials: a systematic review of the literature. Clinical Trials, 14(4), 387-395.
DOI Scopus28 WoS25 Europe PMC19
2017 Dodd, J., Du Plessis, L., Deussen, A., Grivell, R., Yelland, L., Louise, J., . . . Owens, J. (2017). Paternal obesity modifies the effect of an antenatal lifestyle intervention in women who are overweight or obese on newborn anthropometry. Scientific Reports, 7(1), 1557-1-1557-9.
DOI Scopus8 WoS10 Europe PMC6
2017 Zhou, S., Best, K., Gibson, R., McPhee, A., Yelland, L., Quinlivan, J., & Makrides, M. (2017). Study protocol for a randomised controlled trial evaluating the effect of prenatal omega-3 LCPUFA supplementation to reduce the incidence of preterm birth: the ORIP trial. BMJ Open, 7(9), e018360-1-e018360-9.
DOI Scopus19 WoS21 Europe PMC17
2016 Yelland, L., Gajewski, B., Colombo, J., Gibson, R., Makrides, M., & Carlson, S. (2016). Predicting the effect of maternal docosahexaenoic acid (DHA) supplementation to reduce early preterm birth in Australia and the United States using results of within country randomized controlled trials. Prostaglandins Leukotrienes and Essential Fatty Acids, 112, 44-49.
DOI Scopus23 WoS22 Europe PMC20
2016 Dodd, J., Newman, A., Moran, L., Deussen, A., Grivell, R., Yelland, L., . . . Robinson, J. (2016). The effect of antenatal dietary and lifestyle advice for women who are overweight or obese on emotional well-being: the LIMIT randomized trial. Acta Obstetricia et Gynecologica Scandinavica, 95(3), 309-318.
DOI Scopus29 WoS26 Europe PMC28
2016 Grivell, R., Yelland, L., Deussen, A., Crowther, C., & Dodd, J. (2016). Antenatal dietary and lifestyle advice for women who are overweight or obese and the effect on fetal growth and adiposity: The LIMIT randomised trial. BJOG: An International Journal of Obstetrics and Gynaecology, 123(2), 233-243.
DOI Scopus37 WoS32 Europe PMC25
2016 Dodd, J., Deussen, A., Mohamad, I., Rifas-Shiman, S., Yelland, L., Louise, J., . . . Robinson, J. (2016). The effect of antenatal lifestyle advice for women who are overweight or obese on secondary measures of neonatal body composition: The LIMIT randomised trial. BJOG: An International Journal of Obstetrics and Gynaecology, 123(2), 244-253.
DOI Scopus30 WoS29 Europe PMC25
2016 Yelland, L. N., Sullivan, T. R., Pavlou, M., & Seaman, S. R. (2016). Response to Klebanoff. Paediatric and Perinatal Epidemiology, 30(2), 206.
DOI
2016 Yelland, L., Makrides, M., McPhee, A., Quinlivan, J., & Gibson, R. (2016). Importance of adequate sample sizes in fatty acid intervention trials. Prostaglandins, Leukotrienes and Essential Fatty Acids, 107, 8-11.
DOI Scopus7 WoS6 Europe PMC5
2016 Muhlhausler, B., Yelland, L., McDermott, R., Tapsell, L., McPhee, A., Gibson, R., & Makrides, M. (2016). DHA supplementation during pregnancy does not reduce BMI or body fat mass in children: follow-up of the DHA to Optimize Mother Infant Outcome randomized controlled trial. American Journal of Clinical Nutrition, 103(6), 1489-1496.
DOI Scopus42 WoS40 Europe PMC32
2016 Gould, J., Anderson, A., Yelland, L., Gibson, R., & Makrides, M. (2016). Maternal characteristics influence response to DHA during pregnancy. Prostaglandins, Leukotrienes and Essential Fatty Acids, 108, 5-12.
DOI Scopus15 WoS13 Europe PMC11
2016 Gould, J. F., Treyvaud, K., Yelland, L. N., Anderson, P. J., Smithers, L. G., Gibson, R. A., . . . Makrides, M. (2016). Does n-3 LCPUFA supplementation during pregnancy increase the IQ of children at school age? Follow-up of a randomised controlled trial. BMJ Open, 6(5), e011465-1-e011465-9.
DOI Scopus17 WoS17 Europe PMC11
2016 van Dijk, S., Zhou, J., Peters, T., Buckley, M., Sutcliffe, B., Oytam, Y., . . . Muhlhausler, B. (2016). Effect of prenatal DHA supplementation on the infant epigenome: results from a randomized controlled trial. Clinical Epigenetics, 8(1), 114-1-114-13.
DOI Scopus75 WoS62 Europe PMC57
2015 Martin, K. E., Grivell, R. M., Yelland, L. N., & Dodd, J. M. (2015). The influence of maternal BMI and gestational diabetes on pregnancy outcome. Diabetes Research and Clinical Practice, 108(3), 508-513.
DOI Scopus69 WoS65 Europe PMC57
2015 Yelland, L., Sullivan, T., Voysey, M., Lee, K., Cook, J., & Forbes, A. (2015). Applying the intention-to-treat principle in practice: guidance on handling randomisation errors. Clinical Trials, 12(4), 418-423.
DOI Scopus57 WoS56 Europe PMC47
2015 Gould, J., Anderson, A., Yelland, L., Smithers, L., Skeaff, C., Gibson, R., & Makrides, M. (2015). Association of cord blood vitamin D at delivery with postpartum depression in Australian women. Australian and New Zealand Journal of Obstetrics and Gynaecology, 55(5), 446-452.
DOI Scopus26 WoS27 Europe PMC16
2015 Dodd, J., Kannieappan, L., Grivell, R., Deussen, A., Moran, L., Yelland, L., & Owens, J. (2015). Effects of an antenatal dietary intervention on maternal anthropometric measures in pregnant women with obesity. Obesity, 23(8), 1555-1562.
DOI Scopus14 WoS11 Europe PMC10
2015 Dodd, J. M., Ahmed, S., Karnon, J., Umberger, W., Deussen, A. R., Tran, T., . . . Robinson, J. S. (2015). The cost-effectiveness of providing antenatal lifestyle advice for women who are overweight or obese: the LIMIT randomised trial. BMC Obesity, 2(1), 14-1-14-9.
DOI Scopus18 Europe PMC16
2015 Yelland, L., Sullivan, T., Pavlou, M., & Seaman, S. (2015). Analysis of randomised trials including multiple births when birth size is informative. Paediatric and Perinatal Epidemiology, 29(6), 567-575.
DOI Scopus25 WoS24 Europe PMC23
2015 Zhou, S., Skeaff, S., Ryan, P., Doyle, L., Anderson, P., Kornman, L., . . . Makrides, M. (2015). The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo-controlled trial. Trials, 16(1), 563-1-563-9.
DOI Scopus48 WoS41 Europe PMC32
2015 Yelland, L. N., Sullivan, T. R., & Makrides, M. (2015). Accounting for multiple births in randomised trials: a systematic review. Archives of Disease in Childhood. Fetal and Neonatal Edition, 100(2), 116-120.
DOI Scopus19 WoS19 Europe PMC17
2014 Szmeja, M., Cramp, C., Grivell, R., Deussen, A., Yelland, L., & Dodd, J. (2014). Use of a DVD to provide dietary and lifestyle information to pregnant women who are overweight or obese: a nested randomised trial. BMC Pregnancy and Childbirth, 14(1), 409-1-409-11.
DOI Scopus26 WoS21 Europe PMC18
2014 Dodd, J., Cramp, C., Sui, Z., Yelland, L., Deussen, A., Grivell, R., . . . Robinson, J. (2014). The effects of antenatal dietary and lifestyle advice for women who are overweight or obese on maternal diet and physical activity: the LIMIT randomised trial. BMC Medicine, 12(1), 161-1-161-19.
DOI Scopus150 WoS131 Europe PMC112
2014 Dodd, J., McPhee, A., Turnbull, D., Yelland, L., Deussen, A., Grivell, R., . . . Robinson, J. (2014). The effects of antenatal dietary and lifestyle advice for women who are overweight or obese on neonatal health outcomes: the LIMIT randomised trial. BMC Medicine, 12(1), 163-1-163-9.
DOI Scopus76 WoS68 Europe PMC63
2014 Dodd, J., Turnbull, D., McPhee, A., Deussen, A., Grivell, R., Yelland, L., . . . Robinson, J. (2014). Antenatal lifestyle advice for women who are overweight or obese: LIMIT randomised trial. BMJ, 348(3), 1-12.
DOI Scopus433 WoS382 Europe PMC343
2014 Dodd, J., Turnbull, D., McPhee, A., Deussen, A., Grivell, R., Yelland, L., . . . Robinson, J. (2014). Antenatal lifestyle advice for women who are overweight or obese: LIMIT randomised trial. Obstetrical and Gynecological Survey, 69(6), 311-313.
DOI Scopus3 WoS2
2014 Bain, E., Middleton, P., Yelland, L., Ashwood, P., & Crowther, C. (2014). Maternal adverse effects with different loading infusion rates of antenatal magnesium sulphate for preterm fetal neuroprotection: the IRIS randomised trial. BJOG, 121(5), 595-603.
DOI Scopus11 WoS9 Europe PMC5
2014 Muhlhausler, B., Gibson, R., Yelland, L., & Makrides, M. (2014). Heterogeneity in cord blood DHA concentration: towards an explanation. Prostaglandins, leukotrienes, and essential fatty acids, 91(4), 135-140.
DOI Scopus26 WoS23 Europe PMC14
2014 Makrides, M., Gould, J., Gawlik, N., Yelland, L., Smithers, L., Anderson, P., & Gibson, R. (2014). Four-year follow-up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA: Journal of the American Medical Association, 311(17), 1802-1804.
DOI Scopus73 WoS62 Europe PMC47
2013 Kannieappan, L., Deussen, A., Grivell, R., Yelland, L., & Dodd, J. (2013). Developing a tool for obtaining maternal skinfold thickness measurements and assessing inter-observer variability among pregnant women who are overweight and obese. BMC Pregnancy and Childbirth, 13(1), 42-48.
DOI Scopus38 WoS31 Europe PMC30
2013 Tu, W., Muhlhausler, B., Yelland, L., & Gibson, R. (2013). Correlations between blood and tissue omega-3 LCPUFA status following dietary ALA intervention in rats. Prostaglandins Leukotrienes and Essential Fatty Acids, 88(1), 53-60.
DOI Scopus48 WoS47 Europe PMC39
2012 Crowther, C., Aghajafari, F., Askie, L., Asztalos, E., Brocklehurst, P., Bubner, T., . . . Zhang, Y. (2012). Repeat prenatal corticosteroid prior to preterm birth: a systematic review and individual participant data meta-analysis for the PRECISE study group (prenatal repeat corticosteroid international IPD study group: assessing the effects using the best level of evidence) - study protocol. Systematic Reviews, 1(12), 1-10.
DOI Scopus17 WoS16 Europe PMC12
2012 Piteo, A., Yelland, L., & Makrides, M. (2012). Does maternal depression predict developmental outcome in 18 month old infants?. Early Human Development, 88(8), 651-655.
DOI Scopus51 WoS49 Europe PMC45
2012 Zhou, S., Yelland, L., McPhee, A., Quinlivan, J., Gibson, R., & Makrides, M. (2012). Fish-oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition, 95(6), 1378-1384.
DOI Scopus120 WoS104 Europe PMC88
2012 Crowther, C., Hague, W., Middleton, P., Baghurst, P., McPhee, A., Tran, T., . . . Robinson, J. (2012). The IDEAL study: investigation of dietary advice and lifestyle for women with borderline gestational diabetes: a randomised controlled trial - study protocol. BMC Pregnancy and Childbirth, 12(106), 2-8.
DOI Scopus16 WoS15 Europe PMC8
2011 Makrides, M., Yelland, L., & Gibson, R. (2011). Maternal depression and child development after prenatal DHA supplementation: Reply. JAMA - Journal of the American Medical Association, 305(4), 360-361.
DOI Europe PMC4
2011 Yelland, L., Salter, A., & Ryan, P. (2011). Performance of the modified poisson regression approach for estimating relative risks from clustered prospective data. American Journal of Epidemiology, 174(8), 984-992.
DOI Scopus365 WoS360 Europe PMC350
2011 Yelland, L., Salter, A., & Ryan, P. (2011). Relative risk estimation in randomized controlled trials: A comparison of methods for independent observations. The International Journal of Biostatistics, 7(1), 2-33.
DOI Scopus32 WoS41
2011 Yelland, L., Salter, A., & Ryan, P. (2011). Relative risk estimation in cluster randomized trials: A comparison of generalized estimating equation methods. The International Journal of Biostatistics, 7(1), 2-28.
DOI Scopus18 WoS2
2011 Yelland, L., Salter, A., Ryan, P., & Makrides, M. (2011). Analysis of binary outcomes from randomised trials including multiple births: when should clustering be taken into account?. Paediatric and Perinatal Epidemiology, 25(3 Sp Iss), 283-297.
DOI Scopus25 WoS25 Europe PMC25
2011 Yelland, L., Salter, A., Ryan, P., & Laurence, C. (2011). Adjusted intraclass correlation coefficients for binary data: methods and estimates from a cluster-randomized trial in primary care. Clinical Trials, 8(1), 48-58.
DOI Scopus33 WoS30 Europe PMC29
2010 Makrides, M., Gibson, R., McPhee, A., Yelland, L., Quinlivan, J., Ryan, P., . . . Griffith, E. (2010). Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: A randomized controlled trial. Jama-journal of the American Medical Association, 304(15), 1675-1683.
DOI Scopus487 WoS432 Europe PMC355
2010 Yelland, L., Gialamas, A., Laurence, C., Willson, K., Ryan, P., Beilby, J., . . . Worley, P. (2010). Assessing agreement between point of care and pathology laboratory results for INR: experiences from the Point of Care Testing in General Practice Trial. Pathology, 42(2), 155-159.
DOI Scopus8 WoS7 Europe PMC5
2010 Gialamas, A., Laurence, C., Yelland, L., Tideman, P., Worley, P., Shephard, M., . . . Beilby, J. (2010). Assessing agreement between point of care and laboratory results for lipid testing from a clinical perspective. Clinical Biochemistry, 43(4-5), 515-518.
DOI Scopus17 WoS19 Europe PMC15
2010 Laurence, C., Gialamas, A., Bubner, T., Yelland, L., Willson, K., Ryan, P., . . . Worley, P. (2010). Patient satisfaction with point-of-care testing in general practice. British Journal of General Practice, 60(572), 166-171.
DOI Scopus59 WoS77 Europe PMC65
2010 Makrides, M., Gibson, R. A., McPhee, A. J., Yelland, L., Quinlivan, J., & Ryan, P. (2010). Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: A randomized controlled trial (1). Revista Chilena De Obstetricia Y Ginecologia, 75(6), 422-424.
2009 Gialamas, A., Yelland, L., Ryan, P., Willson, K., Laurence, C., Bubner, T., . . . Beilby, J. (2009). Does point-of-care testing lead to the same or better adherence to medication? A randomised controlled trial: the PoCT in General Practice Trial. Medical Journal of Australia, 191(9), 487-491.
DOI Scopus72 WoS65 Europe PMC54
2009 Bubner, T., Laurence, C., Gialamas, A., Yelland, L., Ryan, P., Willson, K., . . . Beilby, J. (2009). Effectiveness of point-of-care testing for therapeutic control of chronic conditions: results from the PoCT in General Practice Trial. Medical Journal of Australia, 190(11), 624-626.
DOI Scopus61 WoS61 Europe PMC41
2009 Laurence, C., Gialamas, A., Yelland, L., Bubner, T., Ryan, P., Willson, K., . . . Beilby, J. (2009). Erratum: A pragmatic cluster randomised controlled trial to evaluate the safety, clinical effectiveness, cost effectiveness and satisfaction with point of care testing in a general practice setting - Rationale, design and baseline characteristics (Trials)). Trials, 10(1), 3 pages.
DOI
2008 Laurence, C., Gialamas, A., Yelland, L., Bubner, T., Ryan, P., Willson, K., . . . Beilby, J. (2008). A pragmatic cluster randomised controlled trial to evaluate the safety, clinical effectiveness, cost effectiveness and satisfaction with point of care testing in a general practice setting - rationale, design and baseline characteristics. Trials, 9(50), www1-www14.
DOI Scopus41 WoS46 Europe PMC30
2008 Yelland, L., Burns, J., Sims, N., Salter, A., & White, J. (2008). Inter- and intra-subject variability in ethanol pharmacokinetic parameters: effects of testing interval and dose.. Forensic Science International, 175(1), 65-72.
DOI Scopus12 WoS9 Europe PMC7
2007 Broadhurst, N., Barton, C., Rowett, D., Yelland, L., Matin, D., Gialamas, A., & Beilby, J. (2007). A before and after study of the impact of academic detailing on the use of diagnostic imaging for shoulder complaints in general practice. BMC Family Practice, 8(1), WWW 1-WWW 8.
DOI Scopus16 WoS14 Europe PMC12
2007 Breed, W., Bauer, M., Wade, R., Thitipramote, N., Suwajarat, J., & Yelland, L. (2007). Intra-individual variation in sperm tail length in murine rodents. Journal of Zoology, 272(3), 299-304.
DOI Scopus24 WoS22
2006 Broadhurst, N., Barton, C., Yelland, L., Martin, D., & Beilby, J. (2006). Managing shoulder pain in general practice: The value of academic detailing. Australian Family Physician, 35(9), 751-752.
Scopus9 Europe PMC6
2006 Nelson, M., Reid, C., Ryan, P., Willson, K., & Yelland, L. (2006). Self-reported adherence with medication and cardiovascular disease outcomes in the Second Australian National Blood Pressure Study (ANBP2). Medical Journal of Australia, 185(9), 487-489.
DOI Scopus105 WoS90 Europe PMC77
2006 Broadhurst, N., Barton, C., Rowett, D., Yelland, L., Martin, D., Gialamas, A., & Beilby, J. (2006). Academic detailing and informed use of imaging of the shoulder in general practice. Australasian Musculoskeletal Medicine, 11(1), 28-35.
2005 Barnden, L., Behin-Ain, S., Kwiatek, R., Casse, R., & Yelland, L. (2005). Age related preservation and loss in optimized brain SPECT. Nuclear Medicine Communications, 26(6), 497-503.
DOI Scopus13 WoS11 Europe PMC7

Year Citation
- Lange, K., Sullivan, T. R., Kasza, J., & Yelland, L. (n.d.). Performance of mixed effects models for partially clustered trials. Poster session presented at the meeting of Unknown Conference.
DOI

Date Role Research Topic Program Degree Type Student Load Student Name
2025 Principal Supervisor Statistical Issues in Childhood Follow-up Studies of Randomised Trials Doctor of Philosophy Doctorate Full Time Miss Sareh Roosta
2025 Principal Supervisor Statistical Issues in Childhood Follow-up Studies of Randomised Trials Doctor of Philosophy Doctorate Full Time Miss Sareh Roosta

Date Role Research Topic Program Degree Type Student Load Student Name
2021 - 2025 Principal Supervisor Design Issues for Partially Clustered Trials Doctor of Philosophy Doctorate Full Time Ms Kylie Lange
2017 - 2020 Co-Supervisor Iodine Nutrition in Early Life and Childhood Neurodevelopment and Growth Doctor of Philosophy Doctorate Full Time Mr Molla Mesele Wassie
2014 - 2016 Co-Supervisor Analysis of Longitudinal Data in Perinatal Trials when the Length of Follow-up is Informative Master of Philosophy Master Full Time Miss Tessa Longstaff

Connect With Me

External Profiles

Other Links